Fabrication and Characterization of Surface Engineered Rifampicin Loaded Lipid Nanoparticulate Systems for the Potential Treatment of Tuberculosis: An In Vitro and In Vivo Evaluation

2021 ◽  
Vol 110 (5) ◽  
pp. 2221-2232
Author(s):  
Nimitt V. Chokshi ◽  
Shruti Rawal ◽  
Dhruvi Solanki ◽  
Saumitra Gajjar ◽  
Vivek Bora ◽  
...  
2017 ◽  
Vol 41 ◽  
pp. 344-350 ◽  
Author(s):  
Madhuri Shringirishi ◽  
Alok Mahor ◽  
Rishikesh Gupta ◽  
Sunil Kumar Prajapati ◽  
Kuldeep Bansal ◽  
...  

2009 ◽  
Vol 19 (6) ◽  
pp. 1553-1559 ◽  
Author(s):  
C. Thomas ◽  
O. Patschan ◽  
D. Ketelsen ◽  
I. Tsiflikas ◽  
A. Reimann ◽  
...  

Nanomedicine ◽  
2021 ◽  
Author(s):  
Amanda de Fraga Dias ◽  
Danieli Rosane Dallemole ◽  
Franciele Aline Bruinsmann ◽  
Luiz Fernando Lopes Silva ◽  
Olga Cruz-López ◽  
...  

Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.


2014 ◽  
Vol 40 (5) ◽  
pp. 890-903 ◽  
Author(s):  
Younes Majdouline ◽  
Jacques Ohayon ◽  
Zahra Keshavarz-Motamed ◽  
Marie-Hélène Roy Cardinal ◽  
Damien Garcia ◽  
...  

2021 ◽  
Vol 17 (5) ◽  
pp. 889-900
Author(s):  
Cuizhen Sun ◽  
Dianju He ◽  
Yonghua Qi ◽  
Guiqin Zhang ◽  
Qiujin Huang

In the current study, we hypothesized that the electrospun scaffold chitosan (CS)/polycaprolactone (PCL)/titanium dioxide (TiO2) could be prepared by combining CS, PCL, and TiO2 nanoparticles (TiO2 NPs) using an electrospinning technique for wound dressing applications. The CS/PCL/TiO2 electrospun scaffold was prepared and characterized by UV-Vis, SEM, TEM, FTIR, and XRD analyses. Based on the UV-Vis analysis, the incorporation of CS/PCL on the surface of TiO2 NPs affected their optical properties. Further, CS/PCL and CS/PCL/TiO2 were found to have uniform distribution in fiber diameter with no bead morphology, as confirmed by SEM. The XRD spectrum of the CS/PCL/TiO2 revealed that the TiO2 NPs were adequately mixed with the CS/PCL solution, exhibiting the planes of TiO2 peaks (112), (105), (204), (116), and (301), which aligned well with the lattice structure. The antibacterial activity of CS/PCL/TiO2 against Staphylococcus aureus and Escherichia coli was evaluated using the zone of inhibition method. By testing the cytocompatibility of CS/PCL/TiO2 in vitro, this dressing was found to have a less toxic nature. In addition, In Vivo wound healing studies showed that the dressing prepared with the CS/PCL/TiO2 electrospun scaffold improved wound healing compared to that prepared with CS/PCL alone. The above results strongly support the use of CS/PCL/TiO2 electrospun scaffold as an effective dressing for wound healing.


2012 ◽  
Vol 13 (3) ◽  
pp. 934-943 ◽  
Author(s):  
B. M. Ursekar ◽  
P. S. Soni ◽  
Abhijit A. Date ◽  
M. S. Nagarsenker

2017 ◽  
Vol 15 (2) ◽  
pp. 375-387 ◽  
Author(s):  
M. Shukla ◽  
U. D. S. Sekhon ◽  
V. Betapudi ◽  
W. Li ◽  
D. A. Hickman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document